AGE Pro Non-Invasive Diabetes Detection Device

Non-invasive skin autofluorescence measurement system for advanced glycation end products assessment. Enables early diabetes detection and complication risk stratification. Optical measurement technology without sample collection.

An in vitro detection system for early diagnosis indicators of diabetic nephropathy in human urine. It features multi-channel composite detection with selected indicator combinations including urinary microalbumin, urinary haptoglobin, and urinary creatinine as an internal standard. The system uses dry biochemistry and immunology methods, allows random urine self-testing without invasive procedures, and supports home-based testing with mobile device image upload for server analysis and professional feedback.

An invention patent product (ZL 2017 1 0507989.9) for in vitro detection of early diagnostic markers of diabetic kidney disease in human urine. It is a Class II urine detection product using dry biochemistry and immunology methods with multi-channel composite detection. The system detects urine microalbumin, urine haptoglobin, and urine creatinine as internal standard. It features non-invasive random urine self-testing, stable dry reagents, and can be used for home self-testing with mobile device result upload for server-based analysis and professional feedback.

Biomarker-based diagnostic test for early detection and screening of diabetes mellitus. This test supports the company's focus on early identification and intervention in metabolic diseases. The product is part of comprehensive chronic disease screening offerings.

In vitro diagnostic system for early detection of diabetic kidney disease through urine analysis. Combines dry-reagent technology with multi-channel detection of key biomarkers including urine microalbumin, uromodulin, and creatinine. Enables both clinical laboratory quantitative analysis and point-of-care home testing with mobile result upload and remote interpretation.

A diagnostic test for screening diabetes in at-home and clinical laboratory settings. Supports early detection of this high-prevalence chronic medical condition.

Non-invasive glucose monitoring device for type 2 diabetes management. CE-marked medical device that measures blood glucose without fingerprick sampling. Includes mobile app and professional dashboard for real-time data sharing with healthcare providers. Clinically validated with 16.3% MARD and 99% results in Parkes A+B zones.

A screening and monitoring device for early identification of high-risk patients with diabetic complications including neuropathy and foot ulceration. The system provides rapid assessment for preventive intervention planning.

A portable diagnostic device for continuous blood glucose management utilizing electrochemical biosensor technology. Enables effortless glucose monitoring for improved diabetes management and healthier lifestyle outcomes.

Portable glucose monitoring device for diabetes management and blood glucose measurement in clinical and home settings.

A diagnostic device for monitoring and assessment related to diabetes care in clinical settings. This product supports patient evaluation and management.